SCHEMBL2607397

SCHEMBL2607397

Cc1ccnc2c(C)cccc12

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSMD14 O00487 2/20 0.68
COPS5 Q92905 2/20 0.68
CCR1 P32246 3/20 0.67
CCR8 P51685 3/20 0.67
CCR5 P51681 2/20 0.67
HTR1A P08908 1/20 0.61
ADRA1D P25100 1/20 0.61
ADRA1A P35348 1/20 0.61
ADRA1B P35368 1/20 0.61
L3MBTL1 Q9Y468 3/20 0.55
CYP2A6 P11509 2/20 0.52
CYP1A2 P05177 2/20 0.52
HTT P42858 2/20 0.52
SLC6A2 P23975 1/20 0.52
PARP1 P09874 2/20 0.48
NPC1 O15118 1/20 0.46
HSP90AA1 P07900 1/20 0.46
ALDH1A1 P00352 2/20 0.45
POLB P06746 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13484093 0.87 CCR1 (0.68) PSMD14COPS5CCR1CCR8CCR5
SCHEMBL812451 0.84 HTT (0.70) PSMD14COPS5CCR1CCR8CCR5
SCHEMBL15703126 0.81 PSMD14 (1.00) PSMD14COPS5CCR1CCR8CCR5
SCHEMBL3271557 0.81 PSMD14 (0.61) PSMD14COPS5CCR1CCR8CCR5
SCHEMBL5542191 0.81 PSMD14 (0.61) PSMD14COPS5CCR1CCR8CCR5
SCHEMBL1187430 0.81 HTT (0.72) PSMD14COPS5CCR1CCR8CCR5
SCHEMBL516343 0.81 PSMD14 (0.61) PSMD14COPS5CCR1CCR8CCR5
SCHEMBL29403673 0.81 HTT (0.72) PSMD14COPS5CCR1CCR8CCR5
SCHEMBL21033695 0.81 PSMD14 (0.61) PSMD14COPS5CCR1CCR8CCR5
SCHEMBL4640797 0.81 PSMD14 (0.61) PSMD14COPS5CCR1CCR8CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7692016-B2 Process for the synthesis of quinoline derivatives COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2010-04-06 US claimed
US-20070123708-A1 Process for the synthesis of quinoline derivatives COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2007-05-31 US claimed
WO-2007060685-A1 AN IMPROVED PROCESS FOR THE SYNTHESIS OF QUINOLINE DERIVATIVES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2007-05-31 WO claimed
EP-0039205-B1 SELECTIVE PRODUCTION OF DIALKYLBENZENES MOBIL OIL CORPORATION (US) 1985-01-30 EP claimed
US-4359595-A ZEOLITE CATALYST CONVERSION OF ALCOHOL OR ETHER MOBIL OIL CORPORATION (US) 1982-11-16 US claimed
US-4300011-A FROM HYDROCARBONS USING ZEOLITE CATALYSTS AND HETEROCYCLE ORGANIC NITROGEN COMPOUNDS MOBIL OIL CORPORATION (US) 1981-11-10 US claimed
EP-0039205-A1 Selective production of dialkylbenzenes MOBIL OIL CORPORATION (US) 1981-11-04 EP claimed
EP-2775839-B1 METHODS FOR ASSESSING REPELLANT QUALITY OF ORGANIC MATERIALS AND METHODS AND COMPOSITIONS FOR REPELLING ARTHROPODS UNIV CALIFORNIA (US) 2023-12-06 EP disclosed
US-20230330099-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2023-10-19 US disclosed
CN-110869348-B Pyrrole compound, perfume composition, and cosmetic containing the same 长谷川香料株式会社 2023-09-12 CN disclosed
US-11737351-B2 Organic semiconductor material and organic photoelectric device using the same Raynergy Tek Incorporation (TW) 2023-08-22 US disclosed
US-11737351-B2 Organic semiconductor material and organic photoelectric device using the same Raynergy Tek Incorporation (TW) 2023-08-22 US disclosed
CN-116098279-A Matcha flavor imparting composition 长谷川香料株式会社 2023-05-12 CN disclosed
US-20070123708-A1 Process for the synthesis of quinoline derivatives COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2007-05-31 US disclosed
EP-0039205-B1 SELECTIVE PRODUCTION OF DIALKYLBENZENES MOBIL OIL CORPORATION (US) 1985-01-30 EP disclosed
US-4359595-A ZEOLITE CATALYST CONVERSION OF ALCOHOL OR ETHER MOBIL OIL CORPORATION (US) 1982-11-16 US disclosed
US-4300011-A FROM HYDROCARBONS USING ZEOLITE CATALYSTS AND HETEROCYCLE ORGANIC NITROGEN COMPOUNDS MOBIL OIL CORPORATION (US) 1981-11-10 US disclosed
EP-0039205-A1 Selective production of dialkylbenzenes MOBIL OIL CORPORATION (US) 1981-11-04 EP disclosed
US-4065510-A LITHIUM PHOSPHATE CATALYST DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) 1977-12-27 US disclosed
US-3956420-A CPOLYOLEFIN COMPOSITION FOR ELECTRICAL INSULATIONFERROCENE, 8-SUBSTITUTED QUINOLINE DAINICHI-NIPPON CABLES, LTD. (JA) 1976-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230330099-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 PSMD14 2311/4885COPS5 3658/4885CCR1 3776/4885
US-20070123708-A1 Process for the synthesis of quinoline derivatives NDUFS4, NDUFS3, NDUFS5 PSMD14 2299/4885COPS5 642/4885CCR1 4735/4885
US-11737351-B2 Organic semiconductor material and organic photoelectric device using the same PPOX, GJA1, GJB2 PSMD14 2738/4885COPS5 1314/4885CCR1 2822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.